Emin Halis Akalın (Halis Akalın, E Halis Akalin, Emin Halis Akalin, Halis Akalin)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 23

Top Venues

Infectious diseases & clinical microbiology

Scientific reports

Human vaccines & immunotherapeutics

BMC microbiology

Uludağ Üniversitesi Tıp Fakültesi

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Uludağ Üniversitesi Tıp Fakültesi

Turkey

Professor :: Infectious Diseases and Clinical Microbiology

Publications

Muhammet Çağrı Yıldız, Harun Ağca, Osman Kaya, İlke Selçuk, Pınar Akalın, Emin Halis Akalın
Comparison of the i-test COVID-19 Rapid Antigen Test with Real-Time Reverse Transcriptase PCR. Infectious diseases & clinical microbiology 6 (1) (2024)
Mine Durusu Tanriover, Özlem Altuntaş Aydın, Hatice Rahmet Güner, Orhan Yıldız, İlhami Celik, Sukran Kose, Sila Akhan, Emin Halis Akalın, Aykut Özdarendeli, Serhat Unal, İhsan Ateş, Ateş Kara, null null
The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac -inactivated COVID-19 vaccines. Human vaccines & immunotherapeutics 20 (1) (2024)
Nazmiye Ülkü Tüzemen, Uğur Önal, Osman Merdan, Bekir Akca, Beyza Ener, Cüneyt Özakın, Emin Halis Akalın
Synergistic antibacterial activity of ceftazidime-avibactam in combination with colistin, gentamicin, amikacin, and fosfomycin against carbapenem-resistant Klebsiella pneumoniae. Scientific reports 14 (1) (2024)
Nazmiye Ülkü Tüzemen, Uğur Önal, Osman Merdan, Bekir Akca, Beyza Ener, Emin Halis Akalın, Cüneyt Özakın
Performance comparison of BD Phoenix CPO detect panel with Cepheid Xpert Carba-R assay for the detection of carbapenemase-producing Klebsiella pneumoniae isolates. BMC microbiology 24 (1) (2024)
Muhammet Çağrı Yıldız, Harun Ağca, Osman Kaya, İlke Selçuk, Pınar Akalın, Emin Halis Akalın
Comparison of the i-test COVID-19 Rapid Antigen Test with Real-Time Reverse Transcriptase PCR. Infectious diseases & clinical microbiology 6 (1) (2024)
Nazmiye Ülkü Tüzemen, Uğur Önal, Osman Merdan, Bekir Akca, Beyza Ener, Cüneyt Özakın, Emin Halis Akalın
Synergistic antibacterial activity of ceftazidime-avibactam in combination with colistin, gentamicin, amikacin, and fosfomycin against carbapenem-resistant Klebsiella pneumoniae. Scientific reports 14 (1) (2024)
Mine Durusu Tanriover, Özlem Altuntaş Aydın, Hatice Rahmet Güner, Orhan Yıldız, İlhami Celik, Sukran Kose, Sila Akhan, Emin Halis Akalın, Aykut Özdarendeli, Serhat Unal, İhsan Ateş, Ateş Kara, null null
The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac -inactivated COVID-19 vaccines. Human vaccines & immunotherapeutics 20 (1) (2024)
Nazmiye Ülkü Tüzemen, Uğur Önal, Osman Merdan, Bekir Akca, Beyza Ener, Emin Halis Akalın, Cüneyt Özakın
Performance comparison of BD Phoenix CPO detect panel with Cepheid Xpert Carba-R assay for the detection of carbapenemase-producing Klebsiella pneumoniae isolates. BMC microbiology 24 (1) (2024)
Nazmiye Ülkü Tüzemen, Uğur Önal, Osman Merdan, Bekir Akca, Beyza Ener, Emin Halis Akalın, Cüneyt Özakın
Performance comparison of BD Phoenix CPO detect panel with Cepheid Xpert Carba-R assay for the detection of carbapenemase-producing Klebsiella pneumoniae isolates. BMC microbiology 24 (1) (2024)
Nazmiye Ülkü Tüzemen, Uğur Önal, Osman Merdan, Bekir Akca, Beyza Ener, Cüneyt Özakın, Emin Halis Akalın
Synergistic antibacterial activity of ceftazidime-avibactam in combination with colistin, gentamicin, amikacin, and fosfomycin against carbapenem-resistant Klebsiella pneumoniae. Scientific reports 14 (1) (2024)
Nazmiye Ülkü Tüzemen, Uğur Önal, Osman Merdan, Bekir Akca, Beyza Ener, Cüneyt Özakın, Emin Halis Akalın
Synergistic antibacterial activity of ceftazidime-avibactam in combination with colistin, gentamicin, amikacin, and fosfomycin against carbapenem-resistant Klebsiella pneumoniae. Scientific reports 14 (1) (2024)
Mine Durusu Tanriover, Özlem Altuntaş Aydın, Hatice Rahmet Güner, Orhan Yıldız, İlhami Celik, Sukran Kose, Sila Akhan, Emin Halis Akalın, Aykut Özdarendeli, Serhat Unal, İhsan Ateş, Ateş Kara, null null
The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac -inactivated COVID-19 vaccines. Human vaccines & immunotherapeutics 20 (1) (2024)
Uğur Önal, Emin Halis Akalın
Opportunistic Infections Among Human Immunodeficiency Virus (HIV) Infected Patients in Turkey: A Systematic Review. Infectious diseases & clinical microbiology 5 (2) (2023)
Uğur Önal, Emin Halis Akalın
Opportunistic Infections Among Human Immunodeficiency Virus (HIV) Infected Patients in Turkey: A Systematic Review. Infectious diseases & clinical microbiology 5 (2) (2023)
Muhammed Ali Kizmaz, Abdurrahman Simsek, Figen Aymak, Emin Halis Akalın, Haluk Barbaros Oral, Ferah Budak
The prevalence of HLA-B*57 serotype associated with hypersensitivity reactions in the treatment of HIV infection in the Turkish population. Current HIV research (2023)
Uğur Önal, Nazmiye Ülkü Tüzemen, Pınar Küçükdemirci Kaya, Remzi İşçimen, Nermin Kelebek Girgin, Cüneyt Özakın, Ferda Şöhret Kahveci, Emin Halis Akalın
Evaluation of the combination treatments with intravenous fosfomycin for carbapenem-resistant Klebsiella pneumoniae. Revista da Associacao Medica Brasileira (1992) 69 (11) (2023)
Nazmiye Ülkü Tüzemen, Ayşe Melda Payaslıoğlu, Cüneyt Özakın, Beyza Ener, Emin Halis Akalın
Trends of Bloodstream Infections in a University Hospital During 12 Years. Polish journal of microbiology 71 (3) (2022)
Alpaslan Turkkan, Imran Saglik, Cansu Turan, Ahmet Sahin, Emin Halis Akalın, Beyza Ener, Ateş Kara, Solmaz Celebi, Emre Sahin, Mustafa Hacimustafaoglu
Nine-month course of SARS-CoV-2 antibodies in individuals with COVID-19 infection. Irish journal of medical science 191 (6) (2022)
Abdurrahman Simsek, Muhammed Ali Kizmaz, Eren Cagan, Fatma Dombaz, Gulcin Tezcan, Ali Asan, Demir Kaan Demir, S Haldun Bal, Digdem Y Ermis, Aslı Görek Dilektaşlı, Esra Kazak, Emin Halis Akalın, Haluk Barbaros Oral, Ferah Budak
Assessment of CD39 expression in regulatory T-cell subsets by disease severity in adult and juvenile COVID-19 cases. Journal of medical virology 94 (5) (2022)
Mine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, Orhan Yildiz, İlhami Celik, Hamdi Levent Doganay, Sukran Kose, Sila Akhan, Emin Halis Akalın, Zafer Sezer, Aykut Ozdarendeli, Serhat Unal, null On Behalf Of The Turkovac Study Group
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial. Vaccines 10 (11) (2022)
Pınar Zarakol, Özgen Köseoğlu Eser, Barış Otlu, Öznur Gürpınar, Cüneyt Özakın, Emin Halis Akalın, İftihar Köksal, Serhat Unal
In-vitro activity of fosfomycin against Escherichia coli and Klebsiella pneumoniae bloodstream isolates and frequency of OXA-48, NDM, KPC, VIM, IMP types of carbapenemases in the carbapenem-resistant groups. Journal of chemotherapy (Florence, Italy) (2021)
Sibel Yorulmaz Goktas, Arzu Yılmaztepe Oral, Emel Yılmaz, Emin Halis Akalın, Furkan Guvenc, Güven Özkaya, Hasan Kocaeli, Seref Dogan, Selcuk Yılmazlar, Haluk Barbaros Oral
Diagnostic value of the CSF levels of D-Lactate and pro-inflammatory cytokines (TNF-alpha, IL-6, IL-8 and IL-17) in the patients with suspected nosocomial meningitis. Singapore medical journal (2021)
Vildan Özkocamaz, Fahir Özkalemkaş, Serdar Seyhan, Beyza Ener, Ahmet Ursavaş, Tuba Ersal, Esra Kazak, Ezgi Demirdöğen Çetinoğlu, Reşit Mıstık, Emin Halis Akalın
The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single-Center Study Turkish journal of haematology : official journal of Turkish Society of Haematology 35 (4) (2018)

Emin Halis Akalın.css-eqlu8i{font-size:small;padding-left:4px;} (Halis Akalın, E Halis Akalin, Emin Halis Akalin, Halis Akalin)

Publication Activity (10 Years)

Top Topics

Top Venues

Emin Halis Akalın (Halis Akalın, E Halis Akalin, Emin Halis Akalin, Halis Akalin)